FDA: Risk-based Immunogenicity Testing will Boost Protein Development
The US FDA says draft guidelines on risk-based immunogenicity testing of protein drugs will encourage the pharma industry to continue development efforts.
Archives for February 25, 2013
Pantarhei Sells Stake in Oral Contraceptive JV
Pantarhei Bioscience has sold in Estetra, its oral contraceptive development JV, to partner Uteron Pharma and will use the proceeds to fund further development.
West: Proprietary Products Propped by Packaging and Manufacturing
West Pharmaceuticals says it is still intent on shifting to proprietary products following results from its packaging and contract manufacturing businesses.
Dispatches from Informex
Biopharma CMO Market’s Recent Downturn Could be Short-Lived
Biopharmaceutical CMOs have seen their business slowly shrink as companies seek less volume and smaller batches, but outsourcing is expected to increase over the next three years.